Breaking News Instant updates and real-time market news.

DPLO

Diplomat Pharmacy

16:34
12/01/16
12/01
16:34
12/01/16
16:34

Diplomat Pharmacy to dispense multiple myeloma combination drug

Diplomat Pharmacy will be dispensing Darzalex in combination with Revlimid and dexamethasone or with Velcade and dexamethasone. Darzalex was recently approved by the FDA to treat patients with multiple myeloma who have received at least one other treatment. Darzalex is a monoclonal antibody that works with the immune system and is the first anti-CD38 in the world approved for humans.

DPLO Diplomat Pharmacy

11/03/16
RAJA
11/03/16
DOWNGRADE
RAJA
Market Perform
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst John Ransom downgraded Diplomat Pharmacy to Market Perform citing the disappointing Q3 report which was negatively impacted by slowing Hep C volumes and and $8M in Direct and Indirect Remuneration fees. The analyst cut his 2017 EBITDA estimate by 30% and recommends remaining on the sidelines.
11/03/16
11/03/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fitbit (FIT) downgraded to Neutral from Buy at Mizuho, to Neutral from Buy at Longbow, to Equal Weight from Overweight at Morgan Stanley, to Underweight from Neutral at Piper Jaffray, to Hold from Buy at SunTrust, to Neutral from Buy at Citi, to Underperform from Buy at BofA/Merrill and to Neutral from Outperform at Wedbush. 2. First Solar (FSLR) downgraded to Perform from Outperform at Oppenheimer, to Neutral from Buy at Janney Capital, and to Neutral from Buy at Roth Capital. 3. Brocade (BRCD) downgraded to Sector Perform from Outperform at RBC Capital, to Hold from Buy at Wunderlich, and to Neutral from Buy at DA Davidson. 4. Diplomat Pharmacy (DPLO) downgraded to Market Perform from Outperform at Avondale, to Market Perform from Outperform at Leerink, and to Market Perform from Outperform at Raymond James. 5. Cempra (CEMP) downgraded to Hold from Buy at Stifel and to Neutral from Overweight at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/23/16
FBCO
11/23/16
DOWNGRADE
FBCO
Underperform
Diplomat Pharmacy downgraded to Underperform from Neutral at Credit Suisse
11/23/16
11/23/16
DOWNGRADE
Target $13

Underperform
Diplomat Pharmacy downgraded to Underperform growth concerns at Credit Suisse
As previously reported, Credit Suisse downgraded Diplomat Pharmacy to Underperform from Neutral and lowered its price target to $13 from $18. Analyst Robert Willoughby has concerns regarding Diplomat's slowing organic growth, limited competitive advantages, and profit challenges. The analyst lowered estimates and said its invested capital base is "ballooning" and there is no clear pathway to higher ROIC.

TODAY'S FREE FLY STORIES

13:35
12/05/16
12/05
13:35
12/05/16
13:35
General news
NY Fed's overnight reverse repo totaled $168.4 B, with 51 counterparties »

NY Fed's overnight…

FTI

FMC Technologies

$36.35

0.75 (2.11%)

, TKPPY

Technip

$17.80

0.45 (2.59%)

13:31
12/05/16
12/05
13:31
12/05/16
13:31
Hot Stocks
FMC Technologies, Technip shareholders approve business combination »

FMC Technologies (FTI)…

FTI

FMC Technologies

$36.35

0.75 (2.11%)

TKPPY

Technip

$17.80

0.45 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

NVS

Novartis

$69.06

0.89 (1.31%)

13:26
12/05/16
12/05
13:26
12/05/16
13:26
Hot Stocks
Novartis' MPN survey results 'help quantify' daily difficulty of MPN »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AXP

American Express

$72.24

0.38 (0.53%)

13:25
12/05/16
12/05
13:25
12/05/16
13:25
Hot Stocks
Barclays turns focus on American Express toward enterprise strength »

Research firm Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CBS

CBS

$61.26

1.075 (1.79%)

, T

AT&T

$38.81

0.2 (0.52%)

13:22
12/05/16
12/05
13:22
12/05/16
13:22
Hot Stocks
CBS CEO: AT&T will not get Showtime for $5 a month »

CBS (CBS) CEO Moonves…

CBS

CBS

$61.26

1.075 (1.79%)

T

AT&T

$38.81

0.2 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

FRBK

Republic First Bancorp

$5.35

-0.05 (-0.93%)

13:22
12/05/16
12/05
13:22
12/05/16
13:22
Hot Stocks
Republic First Bancorp elects Vernon Hill as chairman »

Republic First Bancorp,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$61.25

1.07 (1.78%)

, T

AT&T

$38.79

0.18 (0.47%)

13:20
12/05/16
12/05
13:20
12/05/16
13:20
Hot Stocks
CBS CEO says will make deal with DirecTV online »

CBS (CBS) CEO Leslie…

CBS

CBS

$61.25

1.07 (1.78%)

T

AT&T

$38.79

0.18 (0.47%)

GOOG

Alphabet

$750.50

2.58 (0.34%)

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

  • 15

    Jan

YUM

Yum! Brands

$63.07

0.65 (1.04%)

13:20
12/05/16
12/05
13:20
12/05/16
13:20
Options
3X average daily option volume in Yum Brands as players gobble up Jan 65 calls »

3X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CBS

CBS

$61.24

1.055 (1.75%)

, T

AT&T

$38.80

0.185 (0.48%)

13:19
12/05/16
12/05
13:19
12/05/16
13:19
Hot Stocks
CBS CEO says in discussions over DirecTV NOW »

Says industry needs total…

CBS

CBS

$61.24

1.055 (1.75%)

T

AT&T

$38.80

0.185 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

$NYE

NYSE Market Internals

13:16
12/05/16
12/05
13:16
12/05/16
13:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:16
12/05/16
12/05
13:16
12/05/16
13:16
Technical Analysis
NASDAQ market internals summary »

Volume is extremely heavy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

, SNY

Sanofi

$40.79

0.77 (1.92%)

13:15
12/05/16
12/05
13:15
12/05/16
13:15
Hot Stocks
Alnylam 'pleased' with updated ALN-CC5 Phase 1/2 trial results »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

SNY

Sanofi

$40.79

0.77 (1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

DPZ

Domino's Pizza

$168.06

0.06 (0.04%)

13:14
12/05/16
12/05
13:14
12/05/16
13:14
Hot Stocks
Domino's locations throughout Phoenix to hire 300 new team members »

Domino's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

CYNO

Cynosure

$44.35

-0.7 (-1.55%)

13:11
12/05/16
12/05
13:11
12/05/16
13:11
Conference/Events
Cynosure management to meet with Maxim »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

GBT

Global Blood Therapeutics

$19.10

-0.1 (-0.52%)

13:11
12/05/16
12/05
13:11
12/05/16
13:11
Hot Stocks
Global Blood Therapeutics announces details on PRO tool in phase 3 HOPE study »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 14

    Dec

  • 15

    Dec

  • 19

    Dec

CBS

CBS

$61.09

0.905 (1.50%)

, NFLX

Netflix

$120.81

3.59 (3.06%)

13:11
12/05/16
12/05
13:11
12/05/16
13:11
Hot Stocks
CBS' Moonves: 2017 will be 'very strong year' for company »

CBS (CBS) CEO Moonves…

CBS

CBS

$61.09

0.905 (1.50%)

NFLX

Netflix

$120.81

3.59 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 12

    Dec

CSIQ

Canadian Solar

$11.07

-0.21 (-1.86%)

13:10
12/05/16
12/05
13:10
12/05/16
13:10
Options
Calls active in Canadian Solar as shares see relative strength »

Calls active in Canadian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

COST

Costco

$152.09

0.35 (0.23%)

13:08
12/05/16
12/05
13:08
12/05/16
13:08
Periodicals
Ontario regulator investigating Costco allegations, STAT reports »

Ontario's Ministry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

13:07
12/05/16
12/05
13:07
12/05/16
13:07
Hot Stocks
Seattle Gen.: Patients in ADCETRIS trial achieve significant durable remissions »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SMCI

Super Micro Computer

$27.00

0.8 (3.05%)

13:07
12/05/16
12/05
13:07
12/05/16
13:07
Conference/Events
Super Micro Computer management to meet with Maxim »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 08

    Feb

  • 09

    Feb

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

13:04
12/05/16
12/05
13:04
12/05/16
13:04
Hot Stocks
Juno announces 'encouraging' preliminary JCAR017 clinical data for NHL patients »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

BLCM

Bellicum Pharmaceuticals

$18.72

1.74 (10.25%)

13:04
12/05/16
12/05
13:04
12/05/16
13:04
Hot Stocks
Bellicum Pharmaceuticals announces GoCAR-T, GoTCR presentations at meeting »

Bellicum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CBS

CBS

$61.03

0.85 (1.41%)

, VIA

Viacom

$40.35

-1 (-2.42%)

13:02
12/05/16
12/05
13:02
12/05/16
13:02
Hot Stocks
CBS CEO: Company 'very happy' as standalone group »

CBS (CBS) chairman and…

CBS

CBS

$61.03

0.85 (1.41%)

VIA

Viacom

$40.35

-1 (-2.42%)

VIAB

Viacom

$36.52

-0.74 (-1.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 12

    Dec

UAL

United Continental

$68.28

-0.99 (-1.43%)

13:02
12/05/16
12/05
13:02
12/05/16
13:02
Hot Stocks
United Continental technicians ratify joint collective bargaining agreement »

United Airlines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTWO

Q2 Holdings

$29.20

0.6 (2.10%)

12:59
12/05/16
12/05
12:59
12/05/16
12:59
Conference/Events
Q2 Holdings management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.